Skip to main content

Table 1 Baseline characteristics of patients categorized according to the presence of CAD (n = 120)

From: Postchallenge responses of nitrotyrosine and TNF-alpha during 75-g oral glucose tolerance test are associated with the presence of coronary artery diseases in patients with prediabetes

Characteristic

CAD (n = 65)

Non-CAD (n = 55)

P values

Age (yrs)

64.9 ± 10.6*

59.1 ± 9.6

< 0.05

Sex (F/M)

13/52*

26/29

< 0.05

SBP (mmHg)

132 ± 22

129 ± 19

0.238

DBP (mmHg)

81 ± 14

77 ± 12

0.163

Body mass index (kg/m2)

26.6 ± 3.3

25.9 ± 4.8

0.835

Waist-to-hip ratio

0.85 ± 0.10

0.83 ± 0.15

0.729

Fasting plasma glucose (mg/dl)

103.3 ± 12.3

101.7 ± 13.3

0.527

Impaired fasting glucose [n (%)]

35 (53.9%)

30 (54.5%)

0.938

HbA1C (%)

5.4 ± 0.9

5.2 ± 0.7

0.725

Family history of CAD [n (%)]

12 (18.4%)

8 (14.5%)

0.815

Past history [n (%)]

   

   Hypercholesterolemia

34 (52.3)

28 (51.0)

0.078

   Hypertension

47 (72.3)

37 (67.2)

0.159

   Alcohol intake

22 (33.8)

22 (40.0)

0.875

   Current smoker

18 (27.7)

14 (25.4)

0.753

Lipid profiles (mg/dL)

   

   Total cholesterol

215 ± 48

208 ± 41

0.238

   LDL cholesterol

127 ± 37

119 ± 42

0.105

   HDL cholesterol

41 ± 10

43 ± 12

0.369

   Triglycerides

217 ± 126

209 ± 138

0.245

Concomitant medication [n (%)]

   

   Aspirin/Clopidogrel

37 (56.9)

25 (45.4)

0.095

   β Adrenergic blockers

18 (27.7)

16 (29.1)

0.358

   Calcium channel blockers

44 (67.7)

36 (65.4)

0.259

   ACE inhibitor/ARB

29 (44.6)

23 (41.8)

0.347

   Diuretics

24 (36.9)

18 (32.7)

0.135

   Statin

33 (50.8)

26 (47.2)

0.085

   Fibrate

5 (7.7)

4 (7.3)

0.468

  1. *P < 0.05; ACE = angiotensin-converting enzyme; ARB: angiotensin II receptor blockers; BMI: body mass index; HbA1C: hemoglobin A1C; HDL: high density lipoprotein; LDL: low density lipoprotein